European patent EP4218671A1, titled 'Devices and Methods for Targeted Delivery of a Substance,' has been published by the European Patent Office (EPO) with an effective date of March 11, 2026. The patent application was filed by Sanulus Medical, LLC, and lists John S. Pollack and William R. Voss as inventors. The patent covers technologies related to the targeted delivery of substances, which has implications for the pharmaceutical and medical device sectors.

This publication represents the grant of a patent, not a regulatory rule or guidance. While it does not impose direct compliance obligations on regulated entities, it signifies intellectual property protection for specific technologies. Companies operating in the pharmaceutical and medical device industries, particularly those involved in drug delivery systems, should be aware of this patent as it may affect their research, development, and commercialization strategies in the designated European states.